← Back to headlines
Wells Fargo Lowers Price Target for Amphastar Pharmaceuticals
Wells Fargo has reduced its price target for Amphastar Pharmaceuticals, Inc. to $19. The article explores the reasons behind this adjustment by the financial institution.
20 May, 20:43 — 20 May, 20:43
Sources
Showing 1 of 1 sources
